The field of medical physics has struggled with the role of research in recent years, as professional interests have dominated its growth toward clinical service. This article focuses on the subset of medical physics programs within academic medical centers and how a refocused academic mission within these centers should drive and support Discovery and Invention with Ventures and Engineering for Research Translation (DIVERT). A roadmap to a DIVERT-based scholarly research program is discussed here around the core building blocks of: (a) creativity in research and team building, (b) improved quality metrics to assess activity, (c) strategic partnerships and spinoff directions that extend capabilities, and (d) future directions driven by faculty-led initiatives. Within academia, it is the unique discoveries and inventions of faculty that lead to their recognition as scholars, and leads to financial support for their research programs and reconition of their intellectual contributions. Innovation must also be coupled to translation to demonstrate outcome successes. These ingredients are critical for research funding, and the two-decade growth in biomedical engineering research funding is an illustration of this, where technology invention has been the goal. This record can be contrasted with flat funding within radiation oncology and radiology, where a growing fraction of research is more procedure-based. However, some centers are leading the change of the definition of medical physics, by the inclusion or assimilation of researchers in fields such as biomedical engineering, machine learning, or data science, thereby widening the scope for new discoveries and inventions. New approaches to the assessment of research quality can help realize this model, revisiting the measures of success and impact. While research partnerships with large industry are productive, newer efforts that foster enterprise startups are changing how institutions see the benefits of the connection between academic innovation and affiliated startup company formation. This innovation-to-enterprise focus can help to cultivate a broader bandwidth of donor-to-investor networks. There are many predictions on future directions in medical physics, yet the actual inventive and discovery steps come from individual research faculty creativity. All success through a DIVERT model requires that faculty-led initiatives span the gap from invention to translation, with support from institutional leadership at all steps in the process. Institutional investment in faculty through endowments or clinical revenues will likely need to increase in the coming years due to the relative decreasing size of grants. Yet, radiology and radiation oncology are both high-revenue, translational fields, with the capacity to synergistically support clinical and research operations through large infrastructures that are mutually beneficial. These roadmap principles can provide a pathway for committed academic medical physics programs in scholarly leadership that will preserve medical physics as an active part of university academics.

中文翻译：

---

通过学术医疗中心进行医学物理学研究的路线图：DIVERT 模型

近年来，医学物理领域一直在努力发挥研究的作用，因为专业兴趣主导了其向临床服务的发展。本文重点关注学术医学中心内的医学物理项目子集，以及这些中心内重新调整的学术使命应如何通过风险投资和研究工程来推动和支持发现和发明。翻译（转移）。这里围绕以下核心构建模块讨论基于 DIVERT 的学术研究计划的路线图：(a) 研究和团队建设的创造力，(b) 改进评估活动的质量指标，(c) 战略伙伴关系和衍生方向，以扩展能力，以及（d）由教师主导的举措驱动的未来方向。在学术界，正是教师的独特发现和发明使他们获得了学者的认可，并为他们的研究项目提供了财政支持，并重新整合了他们的智力贡献。创新还必须与翻译相结合，以展示成果的成功。这些成分对于研究经费至关重要，生物医学工程研究经费的两个十年的增长就是一个例证，技术发明一直是目标。这一记录与放射肿瘤学和放射学领域的固定资金形成鲜明对比，后者越来越多的研究更加基于程序。然而，一些中心正在引领医学物理学定义的变化，通过纳入或同化生物医学工程、机器学习或数据科学等领域的研究人员，从而扩大新发现和发明的范围。评估研究质量的新方法可以帮助实现这一模型，重新审视成功和影响的衡量标准。虽然与大型企业的研究合作富有成效，但促进企业初创企业的新努力正在改变机构看待学术创新与附属初创公司组建之间联系的好处的方式。这种对企业创新的关注有助于培养更广泛的捐助者到投资者网络。对医学物理学未来方向有很多预测，但实际的发明和发现步骤来自于个别研究人员的创造力。DIVERT 模式的所有成功都需要教师主导的举措跨越从发明到翻译的差距，并在此过程的所有步骤中得到机构领导的支持。由于赠款规模相对减少，未来几年可能需要增加通过捐赠或临床收入对教师的机构投资。然而，放射学和放射肿瘤学都是高收入的转化领域，有能力通过互惠互利的大型基础设施协同支持临床和研究业务。这些路线图原则可以为学术领导力中致力于学术医学物理学项目提供一条途径，从而使医学物理学成为大学学术的积极组成部分。